LOS ANGELES, Dec. 30, 2024 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Kyverna Therapeutics, Inc. ("Kyverna" or the "Company") (NASDAQ: KYTX). Class Period:...
Read More Details
Finally We wish PressBee provided you with enough information of ( KYTX Investors Have Opportunity to Lead Kyverna Therapeutics, Inc. Securities Fraud Lawsuit )
Also on site :
- The Diet That Helped a ’90s Pop Star Reclaim His Life
- 'Full House' Star Jodie Sweetin Sends Strong Message in Latest Personal Update
- This British Rock Band is the World's Top Concert Attraction, 25 Years After Their Debut